Australia markets open in 51 minutes

Evoke Pharma Inc (EV0.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
0.20340.0000 (0.00%)
At close: 08:30AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,106
5,181
2,509
1,618
23.02
Cost of revenue
243.817
201.879
370.394
328.118
86.712
Gross profit
5,862
4,979
2,138
1,290
-63.692
Operating expenses
Research development
119.562
181.907
300.789
590.476
6,555
Selling general and administrative
12,519
12,228
9,624
8,851
6,429
Total operating expenses
12,639
12,410
9,924
9,442
12,984
Operating income or loss
-6,777
-7,431
-7,786
-8,152
-13,047
Interest expense
501.37
500
500
500.05
112.994
Total other income/expenses net
-
-
-
105.13
-
Income before tax
-7,129
-7,792
-8,224
-8,538
-13,155
Income from continuing operations
-7,129
-7,792
-8,224
-8,538
-13,155
Net income
-7,129
-7,792
-8,224
-8,538
-13,155
Net income available to common shareholders
-7,129
-7,792
-8,224
-8,538
-13,155
Basic EPS
-2.27
-2.33
-2.62
-3.18
-6.24
Diluted EPS
-2.27
-2.33
-2.62
-3.18
-6.24
Basic average shares
3,343
3,343
3,144
2,682
2,124
Diluted average shares
3,343
3,343
3,144
2,682
2,124